Diroximel Fumarate

5 trials 2 recruiting LOncology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

2 Completed trials

4 Sponsors

8 Countries

Phase III

Phase II

Phase III: 4 Phase II: 1

Indications tested

Multiple sclerosis relapse 1 Relapsing-remitting multiple sclerosis 1 Relapsing multiple sclerosis 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 2 Biogen Idec Research Limited 1 Les Hopitaux Universitaires De Strasbourg 1 Novartis Pharma AG 1

All trials

5 total

DESIRE MS: A prospective randomized non-inferiority trial comparing anti-CD20 maintenance versus De-Escalation Strategy In Relapsing-Remitti… Pending

2024-513292-40-00 Phase III 1 country Centre Hospitalier Universitaire De Montpellier
DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL Recruiting

2025-522687-33-00 Phase III 1 country Centre Hospitalier Universitaire De Lille
DISEASE MODIFYING THERAPIES WITHDRAWAL IN INACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS AGED 55 AND OVER: A MULTICENTRIC, RANDOMI… Recruiting

2024-513475-41-00 Phase III 1 country Les Hopitaux Universitaires De Strasbourg
A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adult… Ended

2022-502552-31-00 Phase II 7 countries Biogen Idec Research Limited
Study of efficacy and tolerability of ofatumumab vs. First Line disease modifying treatment (DMT) - physician’s choice in the treatment of n… Ended

2023-507431-37-00 Phase III 4 countries Novartis Pharma AG

Showing 1–5 of 5 trials

← All drugs A–Z